Formulation and Evaluation of Canagliflozin-Loaded Nanostructured Lipid Carries

Aim of this research work is to develop and evaluate Canagliflozin-loaded Nanostructured Lipid Carriers (NLCs) to improve the drug’s solubility, oral bioavailability, and therapeutic efficacy in type 2 diabetes mellitus. NLCs was formulated by using suitable solid and liquid lipidswith surfactants, followed by characterization through particle size, zeta potential, entrapment efficiency, in vitrodrug release profile, TEM, and stability evaluation of the optimized formulation. Canagliflozin-loaded NLCs were prepared using a high-speed homogenization method followed by ultrasonication. The prepared NLCs were evaluated for particle size, zeta potential, drug content, entrapment efficiency, and in vitro drug release.TEM analysis was performed to study morphology. Stability studies were carried out in compliance with ICH guidelines. FTIR study was conducted for identifying functional groups and drug-excipient compatibility study and found that they are compatible with each other. The in-vitro drug release profile confirmed improved release characteristics. The optimized formulation (CF3) exhibited favourable particle size of 305 nm, high drug content of 96.23 %, and high entrapment efficiency of 94.56%. TEM images confirmed smooth and spherical particle morphology, indicating successful NLC formation. Stability studies shown good physical stability and there were no significant changes in the physic-chemical properties of formulation. So it was concluded that, the Canagliflozin-loaded NLCs are potential and effective drug delivery system.